title: Letter by Freeman et al regarding article, "Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY Trial".
authors.forename: W David
authors.initials: WD
authors.lastname: Freeman
authors.forename: Ruth
authors.initials: R
authors.lastname: Kuo
authors.forename: Maria I
authors.initials: MI
authors.lastname: Aguilar
mesh_terms: D001281:Atrial Fibrillation; D001562:Benzimidazoles / Q000009:adverse effects*; D005260:Female; D006801:Humans; D020300:Intracranial Hemorrhages; D008297:Male; D014859:Warfarin / Q000009:adverse effects*; D015091:beta-Alanine / Q000031:analogs & derivatives*
chemical_list: D001562:Benzimidazoles; D015091:beta-Alanine; D014859:Warfarin